Mercer Global Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $402K | Buy |
5,034
+38
| +0.8% | +$3.03K | ﹤0.01% | 1656 |
|
2025
Q1 | $430K | Sell |
4,996
-25
| -0.5% | -$2.15K | ﹤0.01% | 1555 |
|
2024
Q4 | $392K | Sell |
5,021
-1,611
| -24% | -$126K | ﹤0.01% | 1586 |
|
2024
Q3 | $470K | Buy |
6,632
+663
| +11% | +$47K | ﹤0.01% | 1365 |
|
2024
Q2 | $411K | Buy |
5,969
+374
| +7% | +$25.7K | ﹤0.01% | 1407 |
|
2024
Q1 | $406K | Sell |
5,595
-174
| -3% | -$12.6K | ﹤0.01% | 1395 |
|
2023
Q4 | $353K | Buy |
5,769
+303
| +6% | +$18.5K | ﹤0.01% | 1514 |
|
2023
Q3 | $313K | Buy |
5,466
+247
| +5% | +$14.1K | ﹤0.01% | 1508 |
|
2023
Q2 | $310K | Sell |
5,219
-151
| -3% | -$8.97K | ﹤0.01% | 1497 |
|
2023
Q1 | $336K | Sell |
5,370
-58
| -1% | -$3.63K | ﹤0.01% | 1439 |
|
2022
Q4 | $340K | Sell |
5,428
-2,182
| -29% | -$137K | ﹤0.01% | 1435 |
|
2022
Q3 | $379K | Buy |
7,610
+59
| +0.8% | +$2.94K | ﹤0.01% | 1284 |
|
2022
Q2 | $444K | Buy |
7,551
+280
| +4% | +$16.5K | ﹤0.01% | 1205 |
|
2022
Q1 | $385K | Buy |
7,271
+228
| +3% | +$12.1K | ﹤0.01% | 1377 |
|
2021
Q4 | $427K | Buy |
7,043
+252
| +4% | +$15.3K | ﹤0.01% | 1287 |
|
2021
Q3 | $381K | Buy |
6,791
+374
| +6% | +$21K | ﹤0.01% | 1313 |
|
2021
Q2 | $334K | Sell |
6,417
-287
| -4% | -$14.9K | ﹤0.01% | 1337 |
|
2021
Q1 | $296K | Buy |
+6,704
| New | +$296K | ﹤0.01% | 1316 |
|